DNA guanine O-6 position (O6-G) (O6-G)

The DNA guanine O-6 position is a specific oxygen atom within the guanine nucleobase that serves as a primary molecular target for alkylating chemotherapeutic agents. Alkylation at this site, particularly methylation or chloroethylation, results in the formation of O6-alkylguanine adducts which are highly cytotoxic and mutagenic (StatPearls, 2023). These adducts disrupt normal DNA base pairing; for instance, O6-methylguanine tends to pair with thymine instead of cytosine during replication (NCBI, 2022). If the cell's mismatch repair (MMR) system attempts to correct this mismatch but the O6-alkyl group remains, it leads to persistent DNA strand breaks and triggers apoptosis (PubMed, 2021). The therapeutic utility of targeting this position is heavily influenced by the activity of O6-methylguanine-DNA methyltransferase (MGMT), a suicide enzyme that removes the alkyl group to restore the guanine base (Journal of Clinical Oncology, 2020). In clinical practice, the methylation status of the MGMT promoter is used as a critical biomarker to predict the responsiveness of tumors, such as glioblastoma, to O6-guanine-targeting drugs like temozolomide (NIH, 2023). This site is also a focus of toxicology, as environmental alkylating agents can cause mutations at this position leading to carcinogenesis (PubChem, 2023).

Other names

O6-guanineO6-alkylguanineO6-methylguanine siteGuanine O6O6-MeG site

Alkylating agents transfer alkyl groups to the O6 position of guanine, creating DNA adducts that cause base-pairing errors and trigger apoptosis via the mismatch repair pathway.